Health Care & Life Sciences » Pharmaceuticals | Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC | Balance Sheet

Fiscal year is July-June. All values GBP Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
27
47
39
61
80
Total Accounts Receivable
29
29
69
67
82
Inventories
30
32
54
57
87
Other Current Assets
1
1
-
-
-
Total Current Assets
86
109
162
185
248
Net Property, Plant & Equipment
18
17
38
45
45
Total Investments and Advances
-
-
-
11
11
Intangible Assets
196
167
355
396
710
Total Assets
303
295
556
638
1,017
ST Debt & Current Portion LT Debt
-
-
2
1
1
Accounts Payable
13
10
24
21
33
Income Tax Payable
6
9
4
3
6
Other Current Liabilities
16
25
36
41
52
Total Current Liabilities
36
44
66
66
92
Long-Term Debt
32
33
154
180
290
Provision for Risks & Charges
1
1
7
6
6
Deferred Taxes
21
16
48
48
93
Other Liabilities
6
3
3
33
28
Total Liabilities
98
100
279
335
512
Common Equity (Total)
205
194
275
301
505
Total Shareholders' Equity
205
194
275
301
505
Total Equity
205
194
277
303
505
Liabilities & Shareholders' Equity
303
295
556
638
1,017
Accumulated Minority Interest
-
-
2
2
-

About Dechra Pharmaceuticals

View Profile
Address
Cheshire Business Park
Northwich Cheshire CW9 7UA
United Kingdom
Employees -
Website http://dechra.com
Updated 07/08/2019
Dechra Pharmaceuticals PLC is a holding company, which engages in the veterinary pharmaceuticals and related products business. It operates through the following segments: European Pharmaceuticals; North American Pharmaceuticals; and Pharmaceuticals Research and Development. The European Pharmaceuticals segment markets and sells licensed pharmaceuticals and specialist pet foods to the veterinary profession in Europe.